News

HRI’s Atherosclerosis and Vascular Remodelling Group, led by Dr Ashish Misra, has published two papers in the prestigious Nature Cardiovascular Research journal, including an analysis of low-dose colchicine use in cardiovascular patients.

This year marks the 10^th annual International Day of Women and Girls in Science, and to celebrate we spoke to several of HRI’s leading female researchers.

Meet Dr Chris Stanley, the leader of HRI's Microvascular Research Group. He is deeply passionate about discovery research and is currently investigating the role of inflammation in blood pressure-related disorders, with a focus on understanding low blood pressure seen in septic shock.

The Heart Research Institute (HRI) is delighted to announce former Olympian Duncan Armstrong OAM is an HRI Ambassador.

Leading scientists at the Heart Research Institute (HRI) are a step closer to uncovering a new biomarker to identify people at risk of heart disease with a simple blood test, after a “good” gene was identified that causes the heart to enlarge with exercise.

The Heart Research Institute (HRI) is delighted to announce that it is one of 13 world-class medical research institutes to receive funding from the NSW Government’s flagship Medical Research Support Program (MRSP).

Delegates from around Australia and the world gathered at the annual Sydney Cardiovascular Symposium.

Researchers from the Heart Research Institute (HRI) attended the 2024 Australian Vascular Biology Society (AVBS) Annual Scientific Meeting from October 16 to 18.

Researchers at the Heart Research Institute (HRI) have made a new discovery, finding an existing drug used to kill tumour cells in cancer patients could also be used to save the limbs of patients with blocked arteries in their legs.